Home > The Spectranetics Salary

The Spectranetics Salary

  • 42
  • 49
  • 15
The Spectranetics average salary is $107,994, median salary is $107,994 with a salary range from $107,994 to $107,994.
The Spectranetics salaries are collected from government agencies and companies. Each salary is associated with a real job position. The Spectranetics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
107,994
Average
107,994
Median
107,994
High
107,994
Total 1 The Spectranetics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Development Engineer 107,994-107,994 Colorado Springs, CO, 80901 2018 The Spectranetics Development Engineer Salaries (1)
The Spectranetics Colorado Springs, CO Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

The Spectranetics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
The Spectranetics Jobs
See more The Spectranetics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
594

All Patents

206

Grant Patents

348

Patents Pending

260

Patents Families

More Recent
The Spectranetics... Information
  • The Spectranetics Corporation
  • Industry: Medical Equipment
  • City: Colorado Sprgs, CO
  • Spectranetics is a medical device Company that develops, manufactures and markets a proprietary excimer laser system and related accessory products for use in minimally invasive surgical procedures within the cardiovascular system. The Company's CVX-300(R) excimer laser is the only system approved by the Food and Drug Administration (FDA) for multiple cardiovascular procedures, including coronary atherectomy and the removal of problematic pacemaker and defibrillator leads. The Company is currently conducting two investigational trials designed to obtain FDA approval to market products in the United States for additional applications.